BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ries J, Agaimy A, Wehrhan F, Baran C, Bolze S, Danzer E, Frey S, Jantsch J, Möst T, Büttner-Herold M, Wickenhauser C, Kesting M, Weber M. Importance of the PD-1/PD-L1 Axis for Malignant Transformation and Risk Assessment of Oral Leukoplakia. Biomedicines 2021;9:194. [PMID: 33669300 DOI: 10.3390/biomedicines9020194] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Deng S, Wang S, Shi X, Zhou H. Microenvironment in Oral Potentially Malignant Disorders: Multi-Dimensional Characteristics and Mechanisms of Carcinogenesis. IJMS 2022;23:8940. [DOI: 10.3390/ijms23168940] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zhou L, Wu Z, Jiang C, Dai S. Efficacy, Safety, and Impact on Patient Survival of PDL1/PD-1 Inhibitors versus FOLFIRINOX Regimens for Advanced Pancreatic Cancer. Comput Math Methods Med 2022;2022:5430720. [PMID: 35761841 DOI: 10.1155/2022/5430720] [Reference Citation Analysis]
3 Nocini R, Vianini M, Girolami I, Calabrese L, Scarpa A, Martini M, Morbini P, Marletta S, Brunelli M, Molteni G, Parwani A, Pantanowitz L, Eccher A. PD-L1 in oral squamous cell carcinoma: A key biomarker from the laboratory to the bedside. Clin Exp Dent Res 2022. [PMID: 35593124 DOI: 10.1002/cre2.590] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Pakkanen E, Kalfert D, Ahtiainen M, Ludvíková M, Kuopio T, Kholová I. PD-L1 and PD-1 expression in thyroid follicular epithelial dysplasia: Hashimoto thyroiditis related atypia and potential papillary carcinoma precursor. APMIS 2022;130:276-83. [PMID: 35238073 DOI: 10.1111/apm.13218] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Capela e Silva F, Lamy E, Castelo PM. Models for Oral Biology Research. Biomedicines 2022;10:952. [DOI: 10.3390/biomedicines10050952] [Reference Citation Analysis]
6 Weber M, Lutz R, Olmos M, Glajzer J, Baran C, Nobis C, Möst T, Eckstein M, Kesting M, Ries J. Beyond PD-L1—Identification of Further Potential Therapeutic Targets in Oral Cancer. Cancers 2022;14:1812. [DOI: 10.3390/cancers14071812] [Reference Citation Analysis]
7 Crawford M, Johnson EH, Liu KYP, Poh C, Tsai RYL. On the Cutting Edge of Oral Cancer Prevention: Finding Risk-Predictive Markers in Precancerous Lesions by Longitudinal Studies. Cells 2022;11:1033. [DOI: 10.3390/cells11061033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Hanna GJ, Villa A, Mistry N, Jia Y, Quinn CT, Turner MM, Felt KD, Pfaff K, Haddad RI, Uppaluri R, Rodig SJ, Woo S, Egloff AM, Hodi FS. Comprehensive Immunoprofiling of High-Risk Oral Proliferative and Localized Leukoplakia. Cancer Research Communications 2021;1:30-40. [DOI: 10.1158/2767-9764.crc-21-0060] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
9 Weber M, Ries J, Wehrhan F, Kesting M. Die Bedeutung des Immunsystems für maligne und entzündliche Erkrankungen in der Mund‑, Kiefer- und Gesichtschirurgie. MKG-Chirurg 2021;14:237-245. [DOI: 10.1007/s12285-021-00322-5] [Reference Citation Analysis]
10 Odell E, Kujan O, Warnakulasuriya S, Sloan P. Oral epithelial dysplasia: Recognition, grading and clinical significance. Oral Dis 2021;27:1947-76. [PMID: 34418233 DOI: 10.1111/odi.13993] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 27.0] [Reference Citation Analysis]
11 Chamoli A, Gosavi AS, Shirwadkar UP, Wangdale KV, Behera SK, Kurrey NK, Kalia K, Mandoli A. Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics. Oral Oncol 2021;121:105451. [PMID: 34329869 DOI: 10.1016/j.oraloncology.2021.105451] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 14.0] [Reference Citation Analysis]
12 Girolami I, Pantanowitz L, Barberis M, Paolino G, Brunelli M, Vigliar E, Munari E, Satturwar S, Troncone G, Eccher A. Challenges facing pathologists evaluating PD-L1 in head & neck squamous cell carcinoma. J Oral Pathol Med 2021. [PMID: 34157159 DOI: 10.1111/jop.13220] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]